Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in High Risk Locally Advanced Rectal Cancer
NCT03170115Phase 2Terminated
- Sponsor
- Instituto Nacional de Câncer José Alencar Gomes da Silva
- Start
- Nov 2017
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rectal cancer comparing Aspirin Arm with Placebo Arm (2 arms). Primary endpoint: Tumor downstaging after induction chemotherapy followed by chemoradiotherapy. Started Nov 2017; status: terminated.
02
Drugs
aspirin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03170115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03170115.